je.st
news
Home
› Synergy Pharmaceuticals Files New Drug Application For Plecanatide In Chronic Idiopathic Constipation
Synergy Pharmaceuticals Files New Drug Application For Plecanatide In Chronic Idiopathic Constipation
2016-02-03 01:28:06| drugdiscoveryonline News Articles
Synergy Pharmaceuticals Inc. recently announced the company has filed with the U.S. Food and Drug Administration (FDA) its first new drug application (NDA) for plecanatide in chronic idiopathic constipation (CIC)
Tags: application
files
drug
chronic
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|